The NHS’ long term survival is at stake – the Ten Year Plan demonstrates the government’s commitment to invest in its recovery, but in order to truly tackle the existential issues at the heart of the ...

A biennial prize fund to promote thought leadership around the big questions affecting health economics. OHE’s educational ...

Our latest research shows respiratory infections cost UK businesses £44 billion a year. Workplace vaccination programs and health-focused policies could help boost productivity, reduce costs, and ...

We conducted a quantitative preference study to understand how well the criteria of NICE’s severity modifier align with UK societal preferences. Our primary objectives were to estimate: Cut-offs for ...

Real-World Evidence (RWE) can provide decision-makers in the healthcare sector with insights into the functioning of health technologies outside of clinical trial settings. In this report, we focus on ...

Despite substantial medical advancements that have transformed HIV into a manageable chronic condition for individuals, the epidemic remains a pressing public health concern in Europe.

This panel brings together leading researchers to explore how health economics can inform policy design in the context of the climate crisis. Rather than proposing new evaluative paradigms, the ...

New antibiotics are urgently needed, but their development is hindered by market failure. A 'volume-delinked model' subscription approach has been suggested to overcome this market failure, providing ...

Our Board of Trustees and advisory committees are essential to guiding our work, maintaining the quality and independence of our research programme and our publications, and ensuring we align with our ...

This report contributes to the understanding of people’s proximity to dementia (e.g., people with dementia and their carers forecast) and so the potential future number of people who will be impacted ...

In this report, we explore the status of access and uptake for NGS testing for lung cancer in Europe, develop the health economic case for NGS testing, and identify barriers and opportunities for ...

Combination therapies (CTs) merge treatments with different mechanisms of action to achieve greater clinical benefits than the individual components alone. CTs are increasingly being used in oncology.